These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 27779153)

  • 1. Cytohistological correlation in pituitary tumor and immunological assessment with the help of Ki-67.
    Sen A; Das C; Mukhopadhyay M; Mukhopadhyay S; Deb S; Mukhopadhyay B
    J Postgrad Med; 2017; 63(2):96-99. PubMed ID: 27779153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Typical and atypical pituitary adenomas: a single-center analysis of outcome and prognosis.
    Chiloiro S; Doglietto F; Trapasso B; Iacovazzo D; Giampietro A; Di Nardo F; de Waure C; Lauriola L; Mangiola A; Anile C; Maira G; De Marinis L; Bianchi A
    Neuroendocrinology; 2015; 101(2):143-50. PubMed ID: 25633744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of prognostic utility of Ki-67, P53, and O-6-methylguanine-DNA methyltransferase expression in pituitary tumors.
    Das C; Mondal P; Mukhopadhyay M; Mukhopadhyay S; Ghosh I; Handral A
    J Lab Physicians; 2019; 11(4):323-329. PubMed ID: 31929698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pituitary tumor transforming gene and insulin-like growth factor 1 receptor expression and immunohistochemical measurement of Ki-67 as potential prognostic markers of pituitary tumors aggressiveness.
    Sánchez-Tejada L; Sánchez-Ortiga R; Moreno-Pérez O; Montañana CF; Niveiro M; Tritos NA; Alfonso AM
    Endocrinol Nutr; 2013; 60(7):358-67. PubMed ID: 23416216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galectin-3 expression in pituitary adenomas as a marker of aggressive behavior.
    Righi A; Morandi L; Leonardi E; Farnedi A; Marucci G; Sisto A; Frank G; Faustini-Fustini M; Zoli M; Mazzatenta D; Agati R; Foschini MP
    Hum Pathol; 2013 Nov; 44(11):2400-9. PubMed ID: 24007691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of pituitary somatotroph adenoma with concomitant secretion of growth hormone, prolactin, and adrenocorticotropic hormone--an adenoma derived from primordial stem cell, studied by immunohistochemistry, in situ hybridization, and cell culture.
    Matsuno A; Sasaki T; Mochizuki T; Fujimaki T; Sanno N; Osamura Y; Teramoto A; Kirino T
    Acta Neurochir (Wien); 1996; 138(8):1002-7. PubMed ID: 8890999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New aspects of tumor pathology of the pituitary].
    Saeger W
    Pathologe; 2015 May; 36(3):293-300. PubMed ID: 25947224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Non-functioning pituitary adenomas: clinical features and immunohistochemistry].
    Ferreira JE; de Mello PA; de Magalhães AV; Botelho CH; Naves LA; Nosé V; Schmitt F
    Arq Neuropsiquiatr; 2005 Dec; 63(4):1070-8. PubMed ID: 16400431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expression profile of PD-L1 and CD8
    Wang PF; Wang TJ; Yang YK; Yao K; Li Z; Li YM; Yan CX
    J Neurooncol; 2018 Aug; 139(1):89-95. PubMed ID: 29680903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunohistochemistry for pituitary hormones and Ki-67 in growth hormone producing pituitary adenomas].
    Brito J; Sáez L; Lemp M; Liberman C; Michelsen H; Araya AV
    Rev Med Chil; 2008 Jul; 136(7):831-6. PubMed ID: 18949157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenocorticotropic hormone secreting pituitary adenomas: analysis of growth fraction using the MIB-1 antibody.
    Mastronardi L; Guiducci A; Spera C; Puzzilli F; Liberati F; Ruggeri A; Peciarolo A
    Tumori; 2000; 86(3):229-32. PubMed ID: 10939604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of Ki-67 antigen in 159 pituitary adenomas using the MIB-1 monoclonal antibody.
    Pizarro CB; Oliveira MC; Coutinho LB; Ferreira NP
    Braz J Med Biol Res; 2004 Feb; 37(2):235-43. PubMed ID: 14762579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minichromosome maintenance protein 7 as prognostic marker of tumor aggressiveness in pituitary adenoma patients.
    Coli A; Asa SL; Fadda G; Scannone D; Chiloiro S; De Marinis L; Lauretti L; Ranelletti FO; Lauriola L
    Eur J Endocrinol; 2016 Mar; 174(3):307-14. PubMed ID: 26620390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early recognition of aggressive pituitary adenomas: a single-centre experience.
    Ceccato F; Regazzo D; Barbot M; Denaro L; Emanuelli E; Borsetto D; Rolma G; Alessio L; Gardiman MP; Lombardi G; Albiger N; D'Avella D; Scaroni C
    Acta Neurochir (Wien); 2018 Jan; 160(1):49-55. PubMed ID: 29170844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polysialylated neural cell adhesion molecules expressed in human pituitary tumors and related to extrasellar invasion.
    Trouillas J; Daniel L; Guigard MP; Tong S; Gouvernet J; Jouanneau E; Jan M; Perrin G; Fischer G; Tabarin A; Rougon G; Figarella-Branger D
    J Neurosurg; 2003 May; 98(5):1084-93. PubMed ID: 12744370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High Ki-67 expression is associated with prolactin secreting pituitary adenomas.
    Bălinişteanu B; Cîmpean AM; Ceauşu AR; Corlan AS; Melnic E; Raica M
    Bosn J Basic Med Sci; 2017 May; 17(2):104-108. PubMed ID: 28432860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical pituitary adenomas: clinical characteristics and role of ki-67 and p53 in prognostic and therapeutic evaluation. A series of 50 patients.
    Del Basso De Caro M; Solari D; Pagliuca F; Villa A; Guadagno E; Cavallo LM; Colao A; Pettinato G; Cappabianca P
    Neurosurg Rev; 2017 Jan; 40(1):105-114. PubMed ID: 27215912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subclinical adenomas in postmortem pituitaries: classification and correlations to clinical data.
    Buurman H; Saeger W
    Eur J Endocrinol; 2006 May; 154(5):753-8. PubMed ID: 16645024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiregional sampling reveals a homogenous distribution of Ki-67 proliferation rate in pituitary adenomas.
    Wolfsberger S; Kitz K; Wunderer J; Czech T; Boecher-Schwarz HG; Hainfellner JA; Knosp E
    Acta Neurochir (Wien); 2004 Dec; 146(12):1323-7; discussion 1327-8. PubMed ID: 15480830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical pituitary adenomas: incidence, clinical characteristics, and implications.
    Zada G; Woodmansee WW; Ramkissoon S; Amadio J; Nose V; Laws ER
    J Neurosurg; 2011 Feb; 114(2):336-44. PubMed ID: 20868211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.